Toxic myopathy and liver damage caused by concomitant therapy with remdesivir, atorvastatin, ezetimibe, and tacrolimus in a renal transplant patient with recently treated SARS‐CoV ‐2 induced pneumonia: A case report-Reference-Cited by-同舟云学术

Toxic myopathy and liver damage caused by concomitant therapy with remdesivir, atorvastatin, ezetimibe, and tacrolimus in a renal transplant patient with recently treated SARS‐CoV ‐2 induced pneumonia: A case report

Published:2021-10-26 Issue: Volume: Page:
ISSN:1744-9979
Container-title:Therapeutic Apheresis and Dialysis
language:en
Short-container-title:Ther Apher Dial

Author:

Sabljić Zoran¹²^ORCID,Bašić‐Jukić Nikolina¹

Affiliation:

1. Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation University Hospital Centre Zagreb Zagreb Croatia

2. Department of Nephrology and Dialysis Varaždin General Hospital Varaždin Croatia

Publisher

Wiley

Subject

Nephrology,Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1744-9987.13748

Reference4 articles.

1. Long-term Safety of Hepatic Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitors

2. Risk for Myopathy With Statin Therapy in High-Risk Patients

3. Combined Therapy with Atorvastatin and Calcineurin Inhibitors: No Interactions with Tacrolimus

4. Compassionate Use of Remdesivir for Patients with Severe Covid-19

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential role of geranylgeraniol in managing statin-associated muscle symptoms: a COVID-19 related perspective;Frontiers in Physiology;2023-11-17

2. Major Genetic Drivers of Statin Treatment Response in African Populations and Pharmacogenetics of Dyslipidemia Through a One Health Lens;OMICS: A Journal of Integrative Biology;2023-11-14

3. Liver Damage and COVID-19: At Least a “Two-Hit” Story in Systematic Review;Current Issues in Molecular Biology;2023-04-04

4. Comparing Neuro-COVID-19 between Waves Requires Clear Cohort Selection;Annals of Indian Academy of Neurology;2023

5. Side effects of anti-lipid medications;Side Effects of Drugs Annual;2023